{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:11:31Z","timestamp":1780708291013,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jinf.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T09:53:25Z","timestamp":1531475605000},"page":"261-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"77","author":[{"given":"Imran","family":"Rizvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0438-4446","authenticated-orcid":false,"given":"Hardeep Singh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Uniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jinf.2018.06.009_bib0001","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1474-4422(13)70168-6","article-title":"Tuberculous meningitis: more questions, still too few answers","volume":"12","author":"Thwaites","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jinf.2018.06.009_bib0002","doi-asserted-by":"crossref","unstructured":"WHO, The World Health Organization. Treatment of tuberculosis: guidelines. 4th Ed. 2010:160. doi:10.1164\/rccm.201012-1949OC.","DOI":"10.1164\/rccm.201012-1949OC"},{"issue":"3","key":"10.1016\/j.jinf.2018.06.009_bib0003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jinf.2009.06.011","article-title":"British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children","volume":"59","author":"Thwaites","year":"2009","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2018.06.009_bib0004","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/ajrccm\/148.3.650","article-title":"Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis","volume":"148","author":"Ellard","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"7","key":"10.1016\/j.jinf.2018.06.009_bib0005","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/AAC.00064-11","article-title":"Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis","volume":"55","author":"Thwaites","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2018.06.009_bib0006","first-page":"352","article-title":"Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis","volume":"131","author":"Tsukamura","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.06.009_bib0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/QCO.0b013e328319bce6","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review","volume":"21","author":"Chan","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"9670","key":"10.1016\/j.jinf.2018.06.009_bib0008","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial","volume":"373","author":"Conde","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jinf.2018.06.009_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2016.01.004","article-title":"Safety and efficacy of additional levofloxacin in tuberculous meningitis: a randomized controlled pilot study","volume":"98","author":"Kalita","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"10.1016\/j.jinf.2018.06.009_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2018.06.009_bib0011","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2018.06.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jinf.2018.06.009_bib0013","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijantimicag.2014.12.027","article-title":"Pharmacokinetic\/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis","volume":"45","author":"Te Brake","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jinf.2018.06.009_bib0014","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/jac\/dku103","article-title":"Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: An open-label randomized controlled trial","volume":"69","author":"Kalita","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2018.06.009_bib0015","doi-asserted-by":"crossref","unstructured":"Thwaites GE, Bang ND, Dung NH, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. October. 2004:1741\u20131751.","DOI":"10.1056\/NEJMoa040573"},{"issue":"7650","key":"10.1016\/j.jinf.2018.06.009_bib0016","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2018.06.009_bib0017","unstructured":"WHO treatment guidelines for drugresistant tuberculosis 2016 update. Geneva: World Health Organization; 2016."},{"key":"10.1016\/j.jinf.2018.06.009_bib0018","doi-asserted-by":"crossref","unstructured":"Heemskerk AD, Thi M, Nguyen H, et al. Clinical outcomes of patients with drug-resistant tuberculous meningitis treated with an intensified antituberculosis regimen. 2017;65:20\u201328. doi:10.1093\/cid\/cix230.","DOI":"10.1093\/cid\/cix230"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:20Z","timestamp":1759008380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318301877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0163445318301877"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.06.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}